How do you effectively guarantee pharmacovigilance in a region that shows significant differences in pharmacovigilance maturity at the country level?
Our experts discuss various aspects, including:
- An overview of the MENA Region
- Available guidelines & Local law
- Personal requirements
- Comparison to EU/US Pharmacovigilance systems
The MENA region holds great promise for the pharmaceutical industry, being potentially hugely profitable. Together these 22 countries have a 350 million population that spends over $30 billion on pharmaceutical products per year and show robust growth. However, it is not a simple task to enter this market due to various factors, including the lack of a centralized pharmaceutical regulator.
In this webinar, we'll focus on pharmacovigilance specifically. The field is getting more and more attention in MENA countries thanks to new regulations and steps in the right direction. It's safe to say that countries like Saudi Arabia, Morocco, Tunisia, and Egypt are relatively advanced in pharmacovigilance. However, others like Libya, Yemen, and Palestine are still taking their first steps in implementing and developing pharmacovigilance systems. Finally, some are still at the very start of development.
10 сен 2024
